Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: Results of a phase II study using a sequential group method

Journal of Clinical Oncology

Volumn 14, Issue 12, 1996, Pages 3097-3104

  Dieras, V ^a   Extra, J M ^a   Bellissant, E ^a   Espie, M ^a   Morvan, F ^a   Pierga, J Y ^a   Mignot, L ^a   Tresca, P ^a   Marty, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; NAVELBINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0029905745     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.12.3097     Document Type: Article

References (29)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. One hundred and thirty three randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:71-85, 1992
2. Henderson IC: Chemotherapy for metastatic disease, in Harris YR, Hellmann S, Henderson IC, et al (eds): Breast Diseases (ed 2). Philadelphia, PA, Lippincott, 1991, pp 604-665
3. Harris JR, Hellman S, Henderson C, et al: Breast Diseases. Philadelphia, PA, Lippincott, 1991
4. Harris JR, Lippman ME, Veronesi U, et al: Breast cancer (first of three parts). N Engl J Med 327:319-328, 1992
5. Ross MB, Buzdar Au, Smith TI, et al: Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer 55:341-346, 1985
6. Tannock IF, Boyd NF, De Boer G, et al: A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6:1377-1387, 1988
7. Habeshaw T, Paul J, Jones R, et al: Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: The results of a randomized trial. J Clin Oncol 9:295-304, 1991
8. French Epirubicin Group: A prospective randomized phase III trial combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. J Clin Oncol 6:679-688, 1988
9. Coombes RC, Bliss JM, Wils J, et al: Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial. J Clin Oncol 14:35-45, 1996
10. Wils J, Bliss JM, Coombes RC, et al: A multicentre randomized trial of tamoxifen versus tamoxifen plus epirubicin in postmenopausal women with node-positive breast cancer. Proc Am Soc Clin Oncol 15:101-109, 1996
11. Potier P: The synthesis of navelbine, prototype of a new series of vinblastine dervatives. Semin Oncol 16:2-4, 1989 (suppl 4)
12. Cros S, Takooudju M, Shaepelynck-Lataste H, et al: Comparative in vitro and in vivo study of navelbine ditartrate (Nor 54 anhydrovinblastine) with the two antitumour compounds: Vinblastine and vincristine. Proceeding of the 14th International Congress of chemotherapy, Kyoto, Japan, June 23-28, 1985. Recent Adv Chemother 1:477-478, 1985
13. Rahmani R, Martin M, Barbet J, et al: Radioimmuno-assay and preliminary pharmacokinetic studies in rats of 5′-Noranhydrovinblastine (Navelbine). Cancer Res 44:5609-5613, 1984
14. Bore P, Rahmani R, Van Canfort J, et al: Pharmacokinetics of a new anticancer drug, Navelbine, in patients. Comparison study of radioimmunologic and radioactive determination methods. Cancer Chemother Pharmacol 23:247-251, 1989
15. Mathe G, Reizenstein P: Phase I pharmacologic study of a new vinca-alkaloid: Navelbine. Cancer Lett 27:285-293, 1985
16. Abeloff MD: Vinorelbine (Navelbine) in the treatment of breast cancer: A summary. Semin Oncol 22:1-4, 41-44, 1995 (suppl 5)
17. Fumoleau P, Delgado FM, Delozier T, et al: Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 11:1245-1252, 1993
18. Spielmann M, Dorval T, Turpin F, et al: Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 12:1764-1770, 1994
19. Chlebowski RT, Pugh RP, Weiner JM, et al: Treatment of advanced breast cancer with 5-fluorouracil. Cancer 48:1711-1714, 1981
20. Margolin KA, Green S, Osborne K, et al: Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer. Am J Clin Oncol 17:175-180, 1994
21. Lokich J: Optimal schedule for 5-fluoro-uracil chemotherapy: Intermittent bolus or continuous infusion. Am J Clin Oncol 8:445-448, 1985
22. Jones AL, Smith IE, O'Brien ME, et al: Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen. J Clin Oncol 12:1259-1265, 1994
23. Bonneterre J, Hebbar M, Fournier CH, et al: FEC iv bolus (group A) vs FEC with fluorouracil (Fu; group B) administered as a continuous infusion on 5 days as first line treatment for metastatic breast cancer: A multicenter randomized study. Proc Am Soc Clin Oncol 14:A153, 1995 (abstr)
24. Bellissant E, Benichou J, Chastang C, et al: Application of the triangular test to phase II cancer clinical trials. Stat Med 9:907-917, 1990
25. Bellissant E, Benichou J, Chastang C: A micro-computer program for the design and analysis of phase II cancer clinical trials with two group sequential methods, the sequential probability ratio test and the triangular test. Comput Biomed Res 27:13-26, 1994
26. Praga C, Beretta G, et al: Adriamycin cardiotoxicity: A survey of 1273 patients. Cancer Treat Rep 63:827-834, 1979
27. Cameron DA, Gabra H, Leonard RC: Continuous 5-fluorouracil in the treatment of breast cancer. Br J Cancer 70:120-124, 1994
28. Marty M, Extra JM, Dieras V, et al: A review of the antitumour activity of vinorelbine in breast cancer. Drugs 44:29-35, 66-69, 1992 (suppl 4)
29. Dieras V, Extra JM, Morvan F, et al: Phase II study of Navelbine and fluorouracil in metastatic breast cancer patients using a group sequential design. Seventh NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, the Netherlands, 1992, p 125